FRAMINGHAM, MA -- (MARKET WIRE) -- August 24, 2006 -- Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today announced the completion of private placements to accredited investors raising over the course of the summer net proceeds of $1,342,340 for an aggregate of 1,366,500 shares of Class A common stock, and a like number of redeemable warrants.
